{"id":249795,"date":"2026-03-31T00:00:00","date_gmt":"2026-03-31T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/biosbi0017-2024-biopharma-biosimilars-forecast-oncology\/"},"modified":"2026-05-06T11:09:04","modified_gmt":"2026-05-06T11:09:04","slug":"biosbi0017-2026-biopharma-biosimilars-forecast-oncology","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/biosbi0017-2026-biopharma-biosimilars-forecast-oncology\/","title":{"rendered":"Biosimilars &#8211; Forecast &#8211; Oncology"},"content":{"rendered":"<p>In 2024, sales of branded <abbr data-abbreviation-entity=\"4880\" title=\"monoclonal antibody\">MAb<\/abbr> biologics in oncology exceeded $48\u00a0billion in the major pharmaceutical markets (United States, <abbr title=\"France, Germany, Italy, Spain, UK\">EU5<\/abbr>, and Japan), and sales of biosimilars totaled $5.9 billion. Throughout the 2024-2034\u00a0forecast period, increasing numbers of branded biologics will lose patent protection, and biosimilars will enter the market and erode patient share and drug prices. We present our forecasts for key reference brands and their biosimilars by molecule and country \/ region.<\/p>\n","protected":false},"template":"","class_list":["post-249795","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-oncology","biopharma-product-biosimilars","biopharma-date-2609"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/249795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":5,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/249795\/revisions"}],"predecessor-version":[{"id":578222,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/249795\/revisions\/578222"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=249795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}